Ana Radeljevic
Director/Miembro de la Junta en MERRIMACK PHARMACEUTICALS, INC. .
Cargos activos de Ana Radeljevic
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 06/06/2022 | - |
| Independent Dir/Board Member | 06/06/2022 | - | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/09/2021 | - |
Historial de carrera de Ana Radeljevic
Antiguos cargos conocidos de Ana Radeljevic.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REVVITY, INC. | Corporate Officer/Principal | 01/01/2014 | 01/01/2016 |
Formación de Ana Radeljevic.
| Syracuse University | Masters Business Admin |
| Old Dominion University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ana Radeljevic
- Experiencia
